Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect
Abstract Background A reliable and effective method is required to deliver agent that can aid the in vivo imaging of retinal vessels. The aim of the present study was to evaluate retro-orbital (RO) injection of fluorescein-labeled isothiocyanate dextran (FITC-dextran) as a method of demonstrating re...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-021-01969-5 |
id |
doaj-08fd6e6b8e4040db985fca08c56598a6 |
---|---|
record_format |
Article |
spelling |
doaj-08fd6e6b8e4040db985fca08c56598a62021-05-11T14:52:55ZengBMCBMC Ophthalmology1471-24152021-05-012111910.1186/s12886-021-01969-5Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defectJizhu Li0Yuqing Wu1Bingqian Liu2Ying Huang3Qingxiu Wu4Haichun Li5Sainan Xiao6Ying Lin7Tao Li8State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityAbstract Background A reliable and effective method is required to deliver agent that can aid the in vivo imaging of retinal vessels. The aim of the present study was to evaluate retro-orbital (RO) injection of fluorescein-labeled isothiocyanate dextran (FITC-dextran) as a method of demonstrating retinal neovascularization (NV) and avascular areas in oxygen-induced retinopathy (OIR) mice. Methods Different concentrations of FITC-dextran were used to compare the efficacy of this agent in perfusing the retinal vessels. Hematoxylin–eosin (HE) staining was used to evaluate the safety of RO injection. The vitreous blood vessels and extent of NV were assessed in P17 OIR mice using FITC-dextran and compared with the corresponding measurements obtained following isolectin B4 staining or the combination of both methods. Results The fluorescence of small vessels and neovascular tufts could be observed clearly following RO injection of 0.05 ml of 25 mg/ml or 50 mg/ml FITC-dextran. No visible damage to tissues adjacent to the injection site was discovered. Vitreous blood flow was gradually reduced from P0 to P5 and eventually disappeared in P17 OIR mice, as demonstrated by FITC-dextran perfusion. The retinal NV areas assessed by isolectin B4 were larger than those assessed by FITC-dextran, but the retinal avascular areas were smaller. The combination of both methods could conduce to distinguish non-functional blood vessels. Conclusions RO injection of FITC-dextran combined with isolectin B4 is an effective, optimal method for assessing the NV area and avascular area.https://doi.org/10.1186/s12886-021-01969-5Retro‐orbital injectionIsolectin B4FITC-dextranNeovascularizationRetinaVitreous blood vessel |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jizhu Li Yuqing Wu Bingqian Liu Ying Huang Qingxiu Wu Haichun Li Sainan Xiao Ying Lin Tao Li |
spellingShingle |
Jizhu Li Yuqing Wu Bingqian Liu Ying Huang Qingxiu Wu Haichun Li Sainan Xiao Ying Lin Tao Li Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect BMC Ophthalmology Retro‐orbital injection Isolectin B4 FITC-dextran Neovascularization Retina Vitreous blood vessel |
author_facet |
Jizhu Li Yuqing Wu Bingqian Liu Ying Huang Qingxiu Wu Haichun Li Sainan Xiao Ying Lin Tao Li |
author_sort |
Jizhu Li |
title |
Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect |
title_short |
Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect |
title_full |
Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect |
title_fullStr |
Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect |
title_full_unstemmed |
Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect |
title_sort |
retro-orbital injection of fitc-dextran combined with isolectin b4 in assessing the retinal neovascularization defect |
publisher |
BMC |
series |
BMC Ophthalmology |
issn |
1471-2415 |
publishDate |
2021-05-01 |
description |
Abstract Background A reliable and effective method is required to deliver agent that can aid the in vivo imaging of retinal vessels. The aim of the present study was to evaluate retro-orbital (RO) injection of fluorescein-labeled isothiocyanate dextran (FITC-dextran) as a method of demonstrating retinal neovascularization (NV) and avascular areas in oxygen-induced retinopathy (OIR) mice. Methods Different concentrations of FITC-dextran were used to compare the efficacy of this agent in perfusing the retinal vessels. Hematoxylin–eosin (HE) staining was used to evaluate the safety of RO injection. The vitreous blood vessels and extent of NV were assessed in P17 OIR mice using FITC-dextran and compared with the corresponding measurements obtained following isolectin B4 staining or the combination of both methods. Results The fluorescence of small vessels and neovascular tufts could be observed clearly following RO injection of 0.05 ml of 25 mg/ml or 50 mg/ml FITC-dextran. No visible damage to tissues adjacent to the injection site was discovered. Vitreous blood flow was gradually reduced from P0 to P5 and eventually disappeared in P17 OIR mice, as demonstrated by FITC-dextran perfusion. The retinal NV areas assessed by isolectin B4 were larger than those assessed by FITC-dextran, but the retinal avascular areas were smaller. The combination of both methods could conduce to distinguish non-functional blood vessels. Conclusions RO injection of FITC-dextran combined with isolectin B4 is an effective, optimal method for assessing the NV area and avascular area. |
topic |
Retro‐orbital injection Isolectin B4 FITC-dextran Neovascularization Retina Vitreous blood vessel |
url |
https://doi.org/10.1186/s12886-021-01969-5 |
work_keys_str_mv |
AT jizhuli retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect AT yuqingwu retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect AT bingqianliu retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect AT yinghuang retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect AT qingxiuwu retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect AT haichunli retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect AT sainanxiao retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect AT yinglin retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect AT taoli retroorbitalinjectionoffitcdextrancombinedwithisolectinb4inassessingtheretinalneovascularizationdefect |
_version_ |
1721443827507527680 |